• Omer Mhf Alanie, Ashish Mahendra, Mairi Mackinnon, Mark McCleery, Christopher Nicholas, and Sanjay Gupta.
• Specialist Registrar, Department of Musculoskeletal Oncology Surgery, Glasgow Royal Infirmary, UK.
• Scot Med J. 2021 Aug 1; 66 (3): 142-147.

Background And AimsIn 2010, a virtual sarcoma referral model was implemented, which aims to provide a centralised multidisciplinary team (MDT) to provide rapid advice, avoiding unnecessary appointments and providing a streamlined service. The aim of this study is to examine the feasibility of this screening tool in reducing the service burden and expediting patient journey.Methods And ResultsAll referrals made to a single tertiary referral sarcoma unit from January 2010 to December 2018 were extracted from a prospective database. Only 26.0% events discussed required review directly. 30.3% were discharged back to referrer. 16.5% required further investigations. 22.5% required a biopsy prior to review. There was a reduction in the rate of patients reviewed at the sarcoma clinic, and a higher discharge rate from the MDT in 2018 versus 2010 (p < 0.001). This gives a potential cost saving of 670,700 GBP over the 9 year period.ConclusionAn MDT meeting which triages referrals is cost-effective at reducing unnecessary referrals. This can limit unnecessary exposure of patients who may have an underlying diagnosis of cancer to a high-risk environment, and reduces burden on services as it copes with increasing demands during the COVID-19 pandemic.

33 keywords...

hide…